Judge favours boosting Sackler payment in Purdue Pharma deal
A judge said Wednesday that he would approve a plan that locks members of the Sackler family who own OxyContin maker Purdue Pharma into pumping at least another US$1.2 billion into a nationwide lawsuit settlement that, if ultimately confirmed, would transform the company into a public trust.